The protective role of IL-1Ra on intestinal ischemia reperfusion injury by anti-oxidative stress via Nrf2/HO-1 pathway in rat

Background: Intestinal ischemia reperfusion injury is a frequent clinical damage, in which the oxidative stress and inflammation play an important role. Interleukin-1 receptor antagonist (IL-1Ra) is a natural anti-inflammatory factor, however, its effect on intestinal ischemia reperfusion injury remains unclear. Methods: The rat model of intestinal I/R was induced by occlusion (for 60 min) and reopening (for 60 min) of superior mesenteric artery. The rats were randomly divided into Interleukin 1 receptor antagonist the following 5 groups: sham-operation(S), model (I/R),10 mg/kgIL-1Ra I/R (C1),20 mg/ kgIL-1Ra I/R (C2), and30 mg/kgIL-1Ra I/R (C3). Results: In this study it was the first time to confirm that IL-1Ra had a significant protection injury against the intestinal ischemia reperfusion injury. IL-1Ra not only effectively inhibited the Protective effect expression of inflammatory factors (such as IL-1 beta, IL-6 and TNF-alpha) and the activation of Nrf2/HO-1 neutrophil in intestinal tissues, but also decreased the death of intestinal cells and the Clinical application damages of intestinal tissues. Interestingly, besides anti-inflammation effect, it was also found that IL-1Ra possessed a significant inhibitory effect on the oxidative stress caused by ischemia/reperfusion injury. Furthermore, the expression of nuclear factor erythroid 2-related factor 2 (Nrf2) and hemeoxygenase-1 (HO-1), and the phosphorylation level of Nrf2 were greatly promoted by IL-1Ra. At the same time, IL-1Ra inhibited the mitogen-activated protein kinase (MAPKs) pathway. Conclusion: IL-1Ra had the protective effect against intestinal ischemia reperfusion injury, its mechanism included anti-inflammation and anti-oxidative stress in which the Nrf2/HO-1 pathway played an important role. The above-mentioned results may extend the clinical application of IL-1Ra in the treatment of intestinal ischemia reperfusion injury.